Skip to main content
Equibles

UBS Group AG

Position in ACXP — Acurx Pharmaceuticals, Inc.

CIK 1610520 ZURICH, V8
Back to ACXP Full portfolio

Position in ACXP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4
-$23,412 QoQ
Shares Held
3
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 19 holders
Holding Since
Jun 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. ACXP ranks #548 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in ACXP

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4 3
2026-03-31 $23,416 6,312
2025-12-31 $420 169
2025-06-30 $19,805 38,759
2025-03-31 $18 47
2024-12-31 $4,852 5,961
2024-06-30 $1,982 881
2023-03-31 $10,047 2,904
2022-12-31 $10,889 2,736
2022-09-30 $12,267 4,089
2022-06-30 $3,945 1,041